Ayberk Akat1, Seda Yilmaz Semerci2, Osman Mutluhan Ugurel1,3, Aysegul Erdemir4, Olivier Danhaive5,6, Merih Cetinkaya2, Dilek Turgut-Balik7. 1. Bioengineering Department, Faculty of Chemical and Metallurgical Engineering, Yıldız Technical University, Davutpasa, Istanbul, Turkey. 2. Neonatal Intensive Care Unit, Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Health Sciences University, Istanbul, Turkey. 3. Department of Basic Sciences, School of Engineering and Architecture, Altınbas University, Istanbul, Turkey. 4. Department of Molecular Biology and Genetics, Faculty of Arts and Science, Yıldız Technical University, Davutpasa, Istanbul, Turkey. 5. Division of Neonatology, St-Luc University Hospital, Catholic University of Louvain, Brussels, Belgium. 6. Division of Neonatology, Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA. 7. Bioengineering Department, Faculty of Chemical and Metallurgical Engineering, Yıldız Technical University, Davutpasa, Istanbul, Turkey. dilekbalik@gmail.com.
Abstract
AIM: Genetic variants contribute to the pathogenesis of bronchopulmonary dysplasia (BPD). The aim of this study is to evaluate the association of 45 SNPs with BPD susceptibility in a Turkish premature infant cohort. METHODS: Infants with gestational age <32 weeks were included. Patients were divided into BPD or no-BPD groups according to oxygen need at 28 days of life, and stratified according to the severity of BPD. We genotyped 45 SNPs, previously identified as BPD risk factors, in 192 infants. RESULTS: A total of eight SNPs were associated with BPD risk at allele level, two of which (rs4883955 on KLF12 and rs9953270 on CHST9) were also associated at the genotype level. Functional relationship maps suggested an interaction between five of these genes, converging on WNT5A, a member of the WNT pathway known to be implicated in BPD pathogenesis. Dysfunctional CHST9 and KLF12 variants may contribute to BPD pathogenesis through an interaction with WNT5A. CONCLUSIONS: We suggest investigating the role of SNPs on different genes which are in relation with the Wnt pathway in BPD pathogenesis. We identified eight SNPs as risk factors for BPD in this study. In-silico functional maps show an interaction of the genes harboring these SNPs with the WNT pathway, supporting its role in BPD pathogenesis. TRIAL REGISTRATION: NCT03467828. IMPACT: It is known that genetic factors may contribute to the development of BPD in preterm infants. Further studies are required to identify specific genes that play a role in the BPD pathway to evaluate them as a target for therapeutic interventions. Our study shows an association of BPD predisposition with certain polymorphisms on MBL2, NFKBIA, CEP170, MAGI2, and VEGFA genes at allele level and polymorphisms on CHST9 and KLF12 genes at both allele and genotype level. In-silico functional mapping shows a functional relationship of these five genes with WNT5A, suggesting that Wnt pathway disruption may play a role in BPD pathogenesis.
AIM: Genetic variants contribute to the pathogenesis of bronchopulmonary dysplasia (BPD). The aim of this study is to evaluate the association of 45 SNPs with BPD susceptibility in a Turkish premature infant cohort. METHODS: Infants with gestational age <32 weeks were included. Patients were divided into BPD or no-BPD groups according to oxygen need at 28 days of life, and stratified according to the severity of BPD. We genotyped 45 SNPs, previously identified as BPD risk factors, in 192 infants. RESULTS: A total of eight SNPs were associated with BPD risk at allele level, two of which (rs4883955 on KLF12 and rs9953270 on CHST9) were also associated at the genotype level. Functional relationship maps suggested an interaction between five of these genes, converging on WNT5A, a member of the WNT pathway known to be implicated in BPD pathogenesis. Dysfunctional CHST9 and KLF12 variants may contribute to BPD pathogenesis through an interaction with WNT5A. CONCLUSIONS: We suggest investigating the role of SNPs on different genes which are in relation with the Wnt pathway in BPD pathogenesis. We identified eight SNPs as risk factors for BPD in this study. In-silico functional maps show an interaction of the genes harboring these SNPs with the WNT pathway, supporting its role in BPD pathogenesis. TRIAL REGISTRATION: NCT03467828. IMPACT: It is known that genetic factors may contribute to the development of BPD in preterm infants. Further studies are required to identify specific genes that play a role in the BPD pathway to evaluate them as a target for therapeutic interventions. Our study shows an association of BPD predisposition with certain polymorphisms on MBL2, NFKBIA, CEP170, MAGI2, and VEGFA genes at allele level and polymorphisms on CHST9 and KLF12 genes at both allele and genotype level. In-silico functional mapping shows a functional relationship of these five genes with WNT5A, suggesting that Wnt pathway disruption may play a role in BPD pathogenesis.
Authors: Alice Hadchouel; Xavier Durrmeyer; Emmanuelle Bouzigon; Roberto Incitti; Johanna Huusko; Pierre-Henri Jarreau; Richard Lenclen; Florence Demenais; Marie-Laure Franco-Montoya; Inès Layouni; Juliana Patkai; Jacques Bourbon; Mikko Hallman; Claude Danan; Christophe Delacourt Journal: Am J Respir Crit Care Med Date: 2011-08-11 Impact factor: 21.405
Authors: Hui Wang; Krystal R St Julien; David K Stevenson; Thomas J Hoffmann; John S Witte; Laura C Lazzeroni; Mark A Krasnow; Cecele C Quaintance; John W Oehlert; Laura L Jelliffe-Pawlowski; Jeffrey B Gould; Gary M Shaw; Hugh M O'Brodovich Journal: Pediatrics Date: 2013-07-29 Impact factor: 7.124
Authors: Jingjing Li; Kun-Hsing Yu; John Oehlert; Laura L Jeliffe-Pawlowski; Jeffrey B Gould; David K Stevenson; Michael Snyder; Gary M Shaw; Hugh M O'Brodovich Journal: Am J Respir Crit Care Med Date: 2015-09-01 Impact factor: 21.405
Authors: Salman Ali; Aaron F Hirschfeld; Matthew L Mayer; Edgardo S Fortuno; Nathan Corbett; Maia Kaplan; Shirley Wang; Julia Schneiderman; Christopher D Fjell; Jin Yan; Loubna Akhabir; Farzian Aminuddin; Nico Marr; Thierry Lacaze-Masmonteil; Richard G Hegele; Allan Becker; Moira Chan-Yeung; Robert E W Hancock; Tobias R Kollmann; Denise Daley; Andrew J Sandford; Pascal M Lavoie; Stuart E Turvey Journal: J Immunol Date: 2013-03-13 Impact factor: 5.422
Authors: A Hilgendorff; K Heidinger; A Pfeiffer; A Bohnert; I R König; A Ziegler; C Merz; G Frey; T Chakraborty; L Gortner; G Bein Journal: Genes Immun Date: 2007-09-27 Impact factor: 2.676